Business Context and Reporting Period
This Form 8-K, dated September 29, 2011, reports a material definitive agreement entered into by Innovative Acquisitions Corp. (the "Company") with Puma Biotechnology, Inc. ("Puma"). The filing details a merger transaction where Puma, a privately-held Delaware corporation, will merge with a wholly-owned subsidiary of the Company, resulting in Puma surviving as a wholly-owned subsidiary.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for either entity. The only specific financial figure disclosed relates to a share redemption:
- Share Redemption: The Company will redeem all currently outstanding shares of common stock for an aggregate purchase price of $40,000 immediately following the closing of the Merger.
- Shareholder Composition: Each stockholder subject to redemption is either a director or officer of the Company, or both.
Material Changes and Transaction Terms
The primary material change is the execution of the Merger Agreement. Key terms include:
- Exchange Ratio: Upon completion, each outstanding share of Puma common stock will convert into the right to receive one share of Company common stock.
- Indemnification: Puma and the Company have agreed to indemnify the Company's officers and directors regarding actions related to the Merger Agreement.
- Management Changes: A condition to closing is the resignation of the Company's current officers and directors.
- Termination Dates: The agreement may be terminated if the Merger is not completed by October 5, 2011, unless Puma extends the deadline to October 14, 2011 under certain circumstances.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary contingencies and risks identified are:
- Closing Conditions: The transaction is subject to customary conditions, including the resignation of current management and the execution of indemnity agreements.
- Time Sensitivity: The transaction faces a strict deadline of October 5, 2011, with a potential extension to October 14, 2011.
Investor Verification Checklist
- Verify the final closing date of the Merger relative to the October 5, 2011 deadline.
- Confirm the resignation of Innovative Acquisitions Corp.'s current officers and directors.
- Review the full text of the Merger Agreement (Exhibit 2.1) and Indemnity Agreement (Exhibit 10.1) for omitted schedules.
- Confirm the successful redemption of the Company's outstanding shares for the $40,000 aggregate price.
- Monitor the post-merger capital structure and the conversion of Puma shares into Company common stock.